Do you need a District of Columbia Birth Injury attorney? Contact one of our District of Columbia Birth Injury attorneys now.
Home : Medical Malpractice & Negligence : Birth Injury : FDA Information
Birth Injury - FDA Information
- The U.S. Food and Drug Administration today launched a national program to bring about the adoption of more uniform, equivalent, and high quality regulatory programs by state agencies responsible for regulating facilities that manufacture, process, pack, or hold food under FDAs jurisdiction.
- FDA's Nanotechnology Task Force today released a report that recommends the agency consider developing guidance and taking other steps to address the benefits and risks of drugs and medical devices using nanotechnology.
- Early Communication about an Ongoing Safety Review Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B) ...
- Guidance for Industry Postmarketing Adverse Event Reporting for Nonprescription Human Drug Products Marketed without an Approved Application ...
- Consumer Drug Information Sheet Actos Brand Name: Actos Active Ingredient:...
- Accutane (isotretinoin) Questions and Answers Revised October 28, 2005: To allow more time for registration and activation, the implementation dates of the iPLEDGE program...
- Patient Information Sheet Sunitinib (marketed as Sutent) PDF Print Version This is a summary of the most important ...
- CDER Report to the Nation: 200 4 Table of Contents Print version ...
- Center for Drug Evaluation and Research Food and Drug Administration Office of Drug Safety Annual Report FY 200 3 ...
- Guidance for Industry Development and Use of Risk Minimization Action Plans (PDF version of this document) U.S....
- Guidance for Industry E2B(M): Data Elements for Transmission of Individual Case Safety Reports (PDF version of this document) ...
- Reviewer Guidance Conducting a Clinical Safety Review of a New Product Application and Preparing a Report on the Review (PDF format of this...
- Package Insert TNKase (Tenecteplase) Genetech, Inc. Table of Contents Description Clinical Pharmacology Clinical Studies Indications and Usage Contraindications ...
- CBER Research Projects Project Title Neurotrophic Factor Function in Neurodegenerative Disease Principal Investigator B. J. Wilcox Laboratory Laboratory of Immunology; Division of...
- FDA Pediatric Ethics Working Group Consensus Statement on thePediatric Advisory Subcommittee?s April 24, 2001 Meeting On April 24, 2001, the Pediatric Advisory Subcommittee met and was...
- CDER Report to the Nation: 2005 Table of Contents Print version ...
Do you need a District of Columbia Birth Injury attorney? Contact one of our District of Columbia Birth Injury attorneys now.
